Felzartamab, Saline Solution Basi 9 mg/ml solution for infusion
299AR201
Phase 2 small_molecule active
Quick answer
Felzartamab, Saline Solution Basi 9 mg/ml solution for infusion for Treatment of Late Isolated Microvascular Inflammation in Recipients of Kidney Transplants is a Phase 2 program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen Idec Ltd
- Indication
- Treatment of Late Isolated Microvascular Inflammation in Recipients of Kidney Transplants
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active